Radiomic Analysis of Magnetic Resonance Imaging for Breast Cancer with TP53 Mutation: A Single Center Study

<b>Background</b>: Radiomics is a non-invasive and cost-effective method for predicting the biological characteristics of tumors. In this study, we explored the association between radiomic features derived from magnetic resonance imaging (MRI) and genetic alterations in patients with breast cancer. <b>Methods</b>: We reviewed electronic medical records of patients with breast cancer patients with available targeted next-generation sequencing data available between August 2018 and May 2021. Substraction imaging of T1-weighted sequences was utilized. The tumor area on MRI was segmented semi-automatically, based on a seeded region growing algorithm. Radiomic features were extracted using the open-source software 3D slicer (version 5.6.1) with PyRadiomics extension. The association between genetic alterations and radiomic features was examined. <b>Results</b>: In total, 166 patients were included in this study. Among the 50 panel genes analyzed, only <i>TP53</i> mutations were significantly associated with radiomic features. Compared with <i>TP53</i> wild-type tumors, <i>TP53</i> mutations were associated with larger tumor size, advanced stage, negative hormonal receptor status, and HER2 positivity. Tumors with <i>TP53</i> mutations exhibited higher values for Gray Level Non-Uniformity, Dependence Non-Uniformity, and Run Length Non-Uniformity, and lower values for Sphericity, Low Gray Level Emphasis, and Small Dependence Low Gray Level emphasis compared to <i>TP53</i> wild-type tumors. Six radiomic features were selected to develop a composite radiomics score. Receiver operating characteristic curve analysis showed an area under the curve of 0.786 (95% confidence interval, 0.719-0.854; <i>p</i> < 0.001). <b>Conclusions</b>: <i>TP53</i> mutations in breast cancer can be predicted using MRI-derived radiomic analysis. Further research is needed to assess whether radiomics can help guide treatment decisions in clinical practice.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2025-02-10
DOI
https://doi.org/10.3390/diagnostics15040428
Citations
2
Primary Topic
Radiomics and Machine Learning in Medical Imaging
Type
article
Field-Weighted Citation Impact
2.72
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Radiomic Analysis of Magnetic Resonance Imaging for Breast Cancer with TP53 Mutation: A Single Center Study

Mi Jung Kwon, Taeryool Koo, Lyo Min Kwon, Yong Joon Suh et al.
2 citations
Diagnostics
Radiomics and Machine Learning in Medical Imaging
2.72
article

Radiomic Analysis of Magnetic Resonance Imaging for Breast Cancer with TP53 Mutation: A Single Center Study

Mi Jung Kwon, Taeryool Koo, Lyo Min Kwon, Yong Joon Suh, Jung Ho Park, Ho Young Kim, Hong Kyu Lee
article en
2 citations

Abstract

<b>Background</b>: Radiomics is a non-invasive and cost-effective method for predicting the biological characteristics of tumors. In this study, we explored the association between radiomic features derived from magnetic resonance imaging (MRI) and genetic alterations in patients with breast cancer. <b>Methods</b>: We reviewed electronic medical records of patients with breast cancer patients with available targeted next-generation sequencing data available between August 2018 and May 2021. Substraction imaging of T1-weighted sequences was utilized. The tumor area on MRI was segmented semi-automatically, based on a seeded region growing algorithm. Radiomic features were extracted using the open-source software 3D slicer (version 5.6.1) with PyRadiomics extension. The association between genetic alterations and radiomic features was examined. <b>Results</b>: In total, 166 patients were included in this study. Among the 50 panel genes analyzed, only <i>TP53</i> mutations were significantly associated with radiomic features. Compared with <i>TP53</i> wild-type tumors, <i>TP53</i> mutations were associated with larger tumor size, advanced stage, negative hormonal receptor status, and HER2 positivity. Tumors with <i>TP53</i> mutations exhibited higher values for Gray Level Non-Uniformity, Dependence Non-Uniformity, and Run Length Non-Uniformity, and lower values for Sphericity, Low Gray Level Emphasis, and Small Dependence Low Gray Level emphasis compared to <i>TP53</i> wild-type tumors. Six radiomic features were selected to develop a composite radiomics score. Receiver operating characteristic curve analysis showed an area under the curve of 0.786 (95% confidence interval, 0.719-0.854; <i>p</i> < 0.001). <b>Conclusions</b>: <i>TP53</i> mutations in breast cancer can be predicted using MRI-derived radiomic analysis. Further research is needed to assess whether radiomics can help guide treatment decisions in clinical practice.

DiagnosticsVol. 15(4)
Hallym University Sacred Heart Hospital (KR)
Good health and well-being
Openalex Percentile: Top 12%
Radiomics and Machine Learning in Medical Imaging
2.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.